| Product Code: ETC12838623 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Estonia`s import shipments of influenza medications primarily came from top exporting countries including Germany, Lithuania, Italy, Slovenia, and Belgium. The market shows a steady growth with a Compound Annual Growth Rate (CAGR) of 8.49% from 2020 to 2024, and a notable growth rate of 9.4% from 2023 to 2024. Despite the increasing imports, the market remains competitive with a very low concentration level, indicating a diverse range of sources for Estonia`s influenza medication imports. This suggests a healthy market dynamics and opportunities for market players in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Influenza Medications Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Estonia Influenza Medications Market - Industry Life Cycle |
3.4 Estonia Influenza Medications Market - Porter's Five Forces |
3.5 Estonia Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Estonia Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Estonia Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Estonia Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early treatment of influenza |
4.2.2 Rising prevalence of influenza cases in Estonia |
4.2.3 Technological advancements in influenza medication development |
4.3 Market Restraints |
4.3.1 Stringent regulations governing the approval and sale of influenza medications |
4.3.2 Limited access to healthcare facilities in remote areas of Estonia |
4.3.3 High competition among pharmaceutical companies in the influenza medication market |
5 Estonia Influenza Medications Market Trends |
6 Estonia Influenza Medications Market, By Types |
6.1 Estonia Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Estonia Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Estonia Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Estonia Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Estonia Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Estonia Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Estonia Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Estonia Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Estonia Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Estonia Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Estonia Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Estonia Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Estonia Influenza Medications Market Import-Export Trade Statistics |
7.1 Estonia Influenza Medications Market Export to Major Countries |
7.2 Estonia Influenza Medications Market Imports from Major Countries |
8 Estonia Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Estonia |
8.2 Percentage of population vaccinated against influenza |
8.3 Rate of adoption of new influenza medications in Estonia |
9 Estonia Influenza Medications Market - Opportunity Assessment |
9.1 Estonia Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Estonia Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Estonia Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Estonia Influenza Medications Market - Competitive Landscape |
10.1 Estonia Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Estonia Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here